BLK Hospital will admit COVID 19 patients

New Delhi: BLK Super Speciality Hospital will begin admissions of Covid-19 patients starting tomorrow, 27th March 2020. The treatment will be available in specially designated isolation wards of their hospital. The hospital is well-equipped with isolation beds, adequate supply of personal protective gear, ventilators and trained staff to support any complex positive cases.

Speaking about the development, Dr Sanjay Mehta, Unit Head and VP, BLK Super Speciality Hospital said, “With such a massive spread world over, we are in support with the government on tackling these cases within the city. While, the ongoing situation has created fear and panic among masses on one hand, it has exerted tremendous pressure on healthcare professionals. However, we are pleased to share that we are well-equipped with sufficient supply of ventilators, ICU and ward beds, trained medical professionals and motivated clinicians. We have already streamlined numerous processes such as isolated designated areas, for first level screening process of patients suspected of having the virus. This is a challenging phase for not only the country but the whole of humanity.”

We will keep adding bed/wards in case there is a surge in the number of COVID-19 positive patients

Related Posts

Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

MOU signed for Patient Referrals, Tele-Consultations and Specialist Healthcare Collaboration Delhi NCR: Unveiled not long ago, Yashoda Medcity’s reputation as being best in class healthcare facility in Delhi NCR has…

Liver enters FATal Straits in India, AIIMS Experts red flag

In first for India, World Congress of Gastroenterology comes calling to asses GI disease burden New Delhi: As global and national burden of digestive diseases reach a critical crossroads, World…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications